MZFClass II
Test, Hiv Detection
21 CFR 866.3956 / Microbiology
MZF is the FDA product code for Test, Hiv Detection, a class II device type, regulated under 21 CFR 866.3956. As of , FDA records hold no 510(k) clearances under this code and one recall.
Classification record
- Product code
- MZF
- Device name
- Test, Hiv Detection
- Regulation
- 21 CFR 866.3956
- Device class
- Class II
- Review panel
- Microbiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 0
- Ingested recalls
- 1
Companies listing this code with FDA
Companies whose registered establishments list this code- Abbott Medical
- Abbott Molecular Distribution Center
- Abbott Molecular, Inc.
- Beckman Coulter Ireland Inc
- Bio-Rad
- Bio-Rad Laboratories Inc.
- Biolytical Laboratories Inc.
- Chembio Diagnostic Systems, Inc.
- CTK Biotech, Inc.
- Diagnostic Automation/ Cortez Diagnostics Inc.
- DiaSorin Italia S.p.A UK Branch
- DiaSorin Italia S.p.A.
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
